The impact of the use of sacubitril/valsartan on clinical and echocardiographic parameters in heart failure patients

Basit Öğe Kaydı
dc.authorid0000-0003-1168-8237
dc.contributor.authorAlmaghraby, Abdallah
dc.contributor.authorAbdelnabi, Mahmoud
dc.contributor.authorKemaloğlu Öz, Tuğba
dc.contributor.authorEl Gowelly, Mohamed
dc.contributor.authorSaleh, Yehia
dc.contributor.authorBadran, Haytham
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:49:34Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:49:34Z
dc.date.issued2019
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalı
dc.descriptionWOS: 000468990702307
dc.description.abstractBackground: Sacubitril/valsartan is a guideline-recommended alternative drug to Angiotensin-Converting enzyme inhibitors (ACEIs) or Angiotensin II Receptor Blockers (ARBs) to reduce morbidity and mortality in patients with chronic heart failure with reduced ejection fraction (HFrEF). Recent guideline update specifically advises switching symptomatic HFrEF patients to sacubitril/valsartan for further reduction of morbidity and mortality. Purpose: The aim of the work was to demonstrate the clinical effects of the use of sacubitril/valsartan instead of the conventional ACEIs or ARBs in HFrEF patients. Methods: A total number of 23 patients with miscellaneous causes of heart failure (14 patients had ischemic etiology, 8 patients had dilated cardiomyopathy and 1 patient had peripartum cardiomyopathy) presented in the setting of heart failure (NYHA III-IV) with normal creatinine clearance. Through clinical examination and baseline 2D transthoracic echocardiography (TTE) was done with an emphasis on left ventricular ejection fraction (LVEF) and end diastolic volume (EDV). All patients received sacubitril/valsartan instead of ACEs inhibitors or ARBs together with beta-blockers, diuretics and Mineralocorticoid antagonists when indicated. Follow-up after 6 months was done to assess patient clinical status as regards heart failure symptoms and follow up TTE as regards LVEF and EDV. Results: The mean age of the patients was 46.89 ± 15.4 years, 14 patients (60.87 %) had a baseline NYHA III while 9 patients (39.13%) had NYHA IV. Mean baseline LVEF and EDV were 27.3% ± 8 and 277.11 ± 57.67 ml respectively. At 6 months follow-up, 21 patients (91.3%) had NYHA I while 2 patients had NYHA II (8.7 %), mean LVEF and EDV were 49.05% ± 10.27 and 202.79 ± 64.86 ml respectively. (P<0.001) Conclusion: According to this small case series, the use of sacubitril/valsartan was not only associated with improvement of heart failure symptoms but also it was linked to evident improvement of TTE parameters in the form of improved LVEF and reduced EDV at 6-months follow-up.
dc.identifier.citationAlmaghraby, A., Abdelnabi, M., Kemaloğlu Öz, T., El Gowelly, M., Saleh, Y. ve Badran, H. M. (2019). The impact of the use of sacubitril/valsartan on clinical and echocardiographic parameters in heart failure patients. European Journal of Heart Failure içinde (240-240. ss.).
dc.identifier.endpage240
dc.identifier.issn1388-9842
dc.identifier.issn1879-0844
dc.identifier.issueSupplement: 1
dc.identifier.startpage240
dc.identifier.urihttps://hdl.handle.net/20.500.12511/1655
dc.identifier.volume21
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofEuropean Journal of Heart Failureen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectSacubitril/Valsartan
dc.subjectHFrEF
dc.subjectAngiotensin II Receptor Blockers (ARBs)
dc.titleThe impact of the use of sacubitril/valsartan on clinical and echocardiographic parameters in heart failure patients
dc.typeConference Object

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Öz, Tuğba Kemaloğlu.pdf
Boyut:
172.33 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Bildiri Koleksiyonu